Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives-Reference-Cited by-同舟云学术

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives

Published:2020-08 Issue: Volume:152 Page:102994
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Leone Gianmarco,Buttigliero Consuelo,Pisano Chiara,Di Stefano Rosario Francesco,Tabbò Fabrizio,Turco Fabio,Vignani Francesca,Scagliotti Giorgio Vittorio^ORCID,Di Maio Massimo^ORCID,Tucci Marcello

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference56 articles.

1. Enzalutamide in metastatic prostate Cancer before chemotherapy;Beer;N. Engl. J. Med.,2014

2. Androgens induce resistance to &em&bcl-2&/em&-mediated apoptosis in LNCaP prostate Cancer cells;Berchem;Cancer Res.,1995

3. Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer;Buttigliero;Cancer Treat. Rev.,2015

4. Androgen receptor gene expression in prostate Cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1;Cai;Cancer Cell,2011

5. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc;Chuu;Cancer Sci.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer;Computational and Structural Biotechnology Journal;2023

2. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer;Cell & Bioscience;2022-12-15

3. Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer;2022-12-10

4. Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells via Apoptosis;Anti-Cancer Agents in Medicinal Chemistry;2022-10

5. Bone Health Management in the Continuum of Prostate Cancer Disease;Cancers;2022-09-02